| Willows Center | |
| 723 Summers Street, Parkersburg, West Virginia 26101 | |
| (304) 428-5573 | |
| Name | Willows Center |
|---|---|
| Location | 723 Summers Street, Parkersburg, West Virginia |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 97 |
| Occupancy Rate | 82.68% |
| Medicare ID (CCN) | 515085 |
| Legal Business Name | 723 Summers Street Operations Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1437195989 |
| Organization Name | HOUSE OF CAMPBELL, INC |
| Doing Business As | WILLOWS CENTER |
| Address | 723 Summers St, Parkersburg, WV 26101 |
| Phone Number | 304-428-5573 |
News Archive
A drive to find out why the United States has the highest rates of treatable sexually transmitted diseases in the developed world has been the career focus of one University of Alabama at Birmingham infectious disease expert.
Stimatix GI, located in the Misgav Venture Accelerator, has reported encouraging interim results in its animal trials of the AOS-C1000 artificial sphincter, designed to provide stoma patients with a new means of bowel control.
In a study to determine the durability and long-term effects of transcranial magnetic stimulation (TMS), psychiatric researchers at Rush University Medical Center have found the non-invasive, non-drug therapy to be an effective, long-term treatment for major depression. Results of the study were published in the October 2010 issue of Brain Stimulation, a journal published by Elsevier.
A new metal nanostructure developed by researchers at the University of California, Santa Cruz, has already shown promise in cancer therapy studies and could be used for chemical and biological sensors and other applications as well.
› Verified 7 days ago
| NPI Number | 1720262918 |
| Organization Name | 723 SUMMERS STREET OPERATIONS LLC |
| Doing Business As | WILLOWS CENTER |
| Address | 723 Summers St, Parkersburg, WV 26101 |
| Phone Number | 304-428-5573 |
News Archive
A drive to find out why the United States has the highest rates of treatable sexually transmitted diseases in the developed world has been the career focus of one University of Alabama at Birmingham infectious disease expert.
Stimatix GI, located in the Misgav Venture Accelerator, has reported encouraging interim results in its animal trials of the AOS-C1000 artificial sphincter, designed to provide stoma patients with a new means of bowel control.
In a study to determine the durability and long-term effects of transcranial magnetic stimulation (TMS), psychiatric researchers at Rush University Medical Center have found the non-invasive, non-drug therapy to be an effective, long-term treatment for major depression. Results of the study were published in the October 2010 issue of Brain Stimulation, a journal published by Elsevier.
A new metal nanostructure developed by researchers at the University of California, Santa Cruz, has already shown promise in cancer therapy studies and could be used for chemical and biological sensors and other applications as well.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A drive to find out why the United States has the highest rates of treatable sexually transmitted diseases in the developed world has been the career focus of one University of Alabama at Birmingham infectious disease expert.
Stimatix GI, located in the Misgav Venture Accelerator, has reported encouraging interim results in its animal trials of the AOS-C1000 artificial sphincter, designed to provide stoma patients with a new means of bowel control.
In a study to determine the durability and long-term effects of transcranial magnetic stimulation (TMS), psychiatric researchers at Rush University Medical Center have found the non-invasive, non-drug therapy to be an effective, long-term treatment for major depression. Results of the study were published in the October 2010 issue of Brain Stimulation, a journal published by Elsevier.
A new metal nanostructure developed by researchers at the University of California, Santa Cruz, has already shown promise in cancer therapy studies and could be used for chemical and biological sensors and other applications as well.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 24.71 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 15.83 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 25.71 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.81 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 5.11 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 12.67 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.49 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 96.19 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 10.95 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 88.51 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.99 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 65.43 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 23 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 8.37 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.03 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 57.65 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 86.29 | 82.93 |
News Archive
A drive to find out why the United States has the highest rates of treatable sexually transmitted diseases in the developed world has been the career focus of one University of Alabama at Birmingham infectious disease expert.
Stimatix GI, located in the Misgav Venture Accelerator, has reported encouraging interim results in its animal trials of the AOS-C1000 artificial sphincter, designed to provide stoma patients with a new means of bowel control.
In a study to determine the durability and long-term effects of transcranial magnetic stimulation (TMS), psychiatric researchers at Rush University Medical Center have found the non-invasive, non-drug therapy to be an effective, long-term treatment for major depression. Results of the study were published in the October 2010 issue of Brain Stimulation, a journal published by Elsevier.
A new metal nanostructure developed by researchers at the University of California, Santa Cruz, has already shown promise in cancer therapy studies and could be used for chemical and biological sensors and other applications as well.
› Verified 7 days ago
Worthington Healthcare Center Location: 2675 36th Street, Parkersburg, West Virginia 26104 Phone: (304) 485-7447 | |
Stonerise Parkersburg Location: 1600 27th Street, Parkersburg, West Virginia 26101 Phone: (304) 485-6476 | |
Ohio Valley Health Care Location: 222 Nicolette Road, Parkersburg, West Virginia 26104 Phone: (304) 485-5137 |